Cite
HARVARD Citation
Amer, K. et al. (2017). Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging. Pharmacotherapy. 37 (6), pp. 657-661. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Amer, K. et al. (2017). Regadenoson versus Dipyridamole: A Comparison of the Frequency of Adverse Events in Patients Undergoing Myocardial Perfusion Imaging. Pharmacotherapy. 37 (6), pp. 657-661. [Online].